WuXi AppTec News & Press Releases | Latest CRDMO Industry Updates & Company Announcements

WuXi AppTec Signs Definitive Agreement to Sell WuXi Advanced Therapies to Altaris, LLC

Philadelphia and Shanghai, 24 December 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has entered into a definitive agreement to sell the US and UK based operations of WuXi Advanced Therapies (ATU), its cell and gene therapy unit, to Altaris, LLC, a healthcare investment firm headquartered in New York.

WuXi AppTec Receives Gold Medal in 2024 EcoVadis Sustainability Rating

Shanghai, November 20, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been awarded a gold medal in the 2024 EcoVadis business sustainability rating, ranking in the top 2% of all participating companies. This achievement reflects WuXi AppTec’s commitment to sustainability and its ongoing efforts to integrate environmental and social responsibilities into the company’s business strategies and operations.

WuXi AppTec's Couvet Site Receives EcoVadis 2024 Silver Medal Rating

Couvet, Switzerland - November 14, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, is proud to announce that its facility in Couvet, Switzerland, has received a silver medal in the 2024 business sustainability ratings by EcoVadis, a leading business sustainability rating provider. This recognition highlights WuXi AppTec’s steadfast commitment to integrating Environmental, Social, and Governance (ESG) priorities into its strategy and operations.

WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

Shanghai, November 11, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Global Corporate Sustainability Assessment (CSA), as of November 11, 2024.

WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year

SHANGHAI, October 29, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a growth advisory firm. This marks the eighth consecutive year that WuXi AppTec has achieved this distinction.